Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Disease-modifying drugs reduce cortical lesion accumulation and atrophy progression in relapsing-remitting multiple sclerosis: results from a 48-month extension study.
Treatment of progressive multiple sclerosis: what works, what does not, and what is needed.
Copolymer-1 promotes neurogenesis and improves functional recovery after acute ischemic stroke in rats.
Santhera's Phase III program with Catena®/Raxone® in Duchenne muscular dystrophy on track to deliver pivotal data early in 2Q 2014
Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study.
Tobacco Smoke-Induced Brain White Matter Myelin Dysfunction: Potential Co-Factor Role of Smoking in Neurodegeneration.
Useful Links
Rituximab product approval information - Licensing action
Biogen Idec and Abbott Announce Enrollment of First Patient in Global Phase III Study of Daclizumab for Relapse-Remitting Multiple Sclerosis
Amyloid fibrils activate B-1a lymphocytes to ameliorate inflammatory brain disease.
Inflammation-induced fatigue: Exploring neurobiological mechanisms and potential treatments
American Society for Cell Biology Annual Meeting
Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis.
Impact of cladribine on soluble adhesion molecules in multiple sclerosis.
Interferon β-1b directly modulates human neural stem/progenitor cell fate.
Launch of a phase 3 clinical trial in the treatment of Alzheimer’s disease with masitinib
Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes.
Forward Pharma Receives Decision to Grant From EPO for DMF Patent in Europe
Society for Neuroscience Annual Meeting
New data from ENDORSE show positive results continued over five years with TECFIDERA® (dimethyl fumarate) in a wide range of multiple sclerosis patients
Thrombotic microangiopathy associated with use of interferon-beta.
The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate.
Novantrone (mitoxantrone HCl) Injection February 2009
Acute transverse myelitis: demyelinating, inflammatory, and infectious myelopathies.
UCSF Seminar: "Antibody Repertoire Sequencing"

Pages